Pfizer has developed pills for COVID-19: their effectiveness is almost 90% - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Pfizer has developed pills for COVID-19: their effectiveness is almost 90%

Pfizer said its COVID-19 pill reduced the risk of hospitalization or death by 89% in a clinical trial. The drug was tested on adults infected with coronavirus who were in high-risk groups for severe disease. The edition told in more detail NPR.

Photo: Shutterstock

The oral medication is called Paxloid. Like the new Merck pill that has been approved in the UKPfizer said their drug has shown good results after five days of treatment since the first symptoms of COVID-19 appeared.

Based on the credibility of the study's findings, Pfizer says it is stopping recruiting people for additional clinical trials of the pill and will instead send the findings to the FDA for emergency use.

“The data shows that our candidate for oral antiviral drugs, if approved or authorized by regulators, could save patient lives, reduce the severity of COVID-19 infections and eliminate up to nine out of ten hospitalizations,” said Pfizer CEO Albert Bourla.

On the subject: Antibiotics for COVID-19: why it is useless and even dangerous

Both antiviral drugs from Pfizer and Merck attack the coronavirus by disrupting its ability to replicate itself.

Pfizer says its pill is boosted by co-administration of a low dose of ritonavir, a drug used in HIV/AIDS treatment regimens. Ritonavir helps protease inhibitors, such as Pfizer's drug, stay in a person's body longer, making them more effective at fighting the virus.

Officials in both the US and the UK say effective COVID-19 pills could be a game-changer in the fight against the pandemic because the pills can be easily taken at home. The Regeneron antibody cocktail has become a key tool in healthcare professionals' efforts to prevent the worst outcomes for people infected with COVID-19, but monoclonal antibody treatment requires either an intravenous infusion or a series of shots.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York

Pfizer says its drug could be prescribed to reduce the severity of illness in COVID-19 patients, as well as to reduce the chances of infection in adults after exposure to the coronavirus.

“It demonstrated potent antiviral activity against circulating variants of concern as well as other known coronaviruses, demonstrating its potential as a therapeutic agent to treat multiple types of coronavirus infections,” the company said when announcing the drug trial results.

Read also on ForumDaily:

World's first pill to treat COVID-19 approved

Biden Administration Will Expand COVID-19 Vaccination Requirements: $14 Fine for Failure to Comply

Top 5 states where salaries have increased dramatically over the past 10 years

How and how much you can earn from participating in clinical trials

pills Educational program Special Projects COVID-19
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1091 requests in 1,317 seconds.